Dona Fleishaker Selected Research

fosdagrocorat

1/2018	In Vitro and In Vivo Investigation of Potential for Complex CYP3A Interaction for PF-00251802 (Dagrocorat), a Novel Dissociated Agonist of the Glucocorticoid Receptor.
8/2017	Improved disease activity with fosdagrocorat (PF-04171327), a partial agonist of the glucocorticoid receptor, in patients with rheumatoid arthritis: a Phase 2 randomized study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Dona Fleishaker Research Topics

Disease

4	Infections 04/2022 - 04/2003
4	Ankylosing Spondylitis 01/2022 - 08/2017
3	Rheumatoid Arthritis 04/2022 - 08/2017
2	Psoriatic Arthritis 04/2022 - 09/2020
1	Headache (Headaches) 04/2022
1	Diarrhea 04/2022
1	Dyspepsia (Indigestion) 04/2022
1	Nausea 04/2022
1	Chronic Disease (Chronic Diseases) 01/2022
1	Back Pain (Backache) 01/2022
1	Pain (Aches) 01/2022
1	Fatigue 01/2022
1	Herpes Zoster 01/2021
1	Inflammation (Inflammations) 01/2018
1	Axial Spondyloarthritis 08/2017
1	Bacteremia 09/2003
1	Pneumonia (Pneumonitis) 09/2003

Drug/Important Bio-Agent (IBA)

6	tofacitinibIBA 04/2022 - 08/2017
3	Janus Kinase InhibitorsIBA 04/2022 - 08/2017
2	fosdagrocoratIBA 01/2018 - 08/2017
2	Glucocorticoid Receptors (Glucocorticoid Receptor)IBA 01/2018 - 08/2017
2	Linezolid (Zyvox)FDA Link 09/2003 - 04/2003
2	Cefadroxil (Duricef)FDA LinkGeneric 09/2003 - 04/2003
1	dagrocoratIBA 01/2018
1	SuspensionsIBA 09/2003
1	Vancomycin FDA LinkGeneric 09/2003
1	Anti-Bacterial Agents (Antibiotics)IBA 04/2003

Therapy/Procedure

1	Therapeutics 01/2022